BioCentury
ARTICLE | Company News

CyGenics, PharmaCell deal

June 12, 2006 7:00 AM UTC

CYN purchased a 20% stake in PharmaCell for an undisclosed amount of cash. In exchange, CYN said it will have access to PharmaCell's cGMP manufacturing facility, where it will manufacture cell therapy...